Skip to content

Innoviva, Inc. INVA Net Investment in Lease

Net Investment in Lease at other companies

Insmed logo
InsmedINSM
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Alkermes logo
AlkermesALKS
LQD
Liquidia CorporationLQDA
Zymeworks logo
ZymeworksZYME

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s net investment in lease?
Innoviva, Inc. (INVA) reported net investment in lease of $10.65M in Q1 2026.
How has Innoviva, Inc.'s net investment in lease changed year-over-year?
Innoviva, Inc.'s net investment in lease increased by 404.8% year-over-year, from $2.11M to $10.65M.
What is the long-term trend for Innoviva, Inc.'s net investment in lease?
Over 4 years (2021 to 2025), Innoviva, Inc.'s net investment in lease has grown at a 225.8% compound annual growth rate (CAGR), from $97K to $10.93M.